Early protective effect of bone marrow mononuclear cells against ischemic white matter damage through augmentation of cerebral blood flow.
about
Heart failure and Alzheimer's diseaseRestoration of oligodendrocyte pools in a mouse model of chronic cerebral hypoperfusionDeveloping Cellular Therapies for StrokeCXCR4(+)CD45(-) BMMNC subpopulation is superior to unfractionated BMMNCs for protection after ischemic stroke in miceBone marrow mononuclear cell transplantation promotes therapeutic angiogenesis via upregulation of the VEGF-VEGFR2 signaling pathway in a rat model of vascular dementiaSystematic Review and Meta-Analysis of Bone Marrow-Derived Mononuclear Cells in Animal Models of Ischemic Stroke.Mouse models to study the effect of cardiovascular risk factors on brain structure and cognitionAutologous cord blood therapy for infantile cerebral palsy: from bench to bedside.Are bone marrow regenerative cells ideal seed cells for the treatment of cerebral ischemia?Nitric oxide facilitates delivery and mediates improved outcome of autologous bone marrow mononuclear cells in a rodent stroke model.Bone marrow mononuclear cells exert long-term neuroprotection in a rat model of ischemic stroke by promoting arteriogenesis and angiogenesis.Impact of age on the efficacy of bone marrow mononuclear cell transplantation in experimental stroke.Intravenous Autologous Bone Marrow Mononuclear Cell Transplantation for Stroke: Phase1/2a Clinical Trial in a Homogeneous Group of Stroke PatientsAutologous Bone Marrow Mononuclear Cells Exert Broad Effects on Short- and Long-Term Biological and Functional Outcomes in Rodents with Intracerebral Hemorrhage.Histopathological Investigation of Different MCAO Modalities and Impact of Autologous Bone Marrow Mononuclear Cell Administration in an Ovine Stroke Model.Increasing Dose of Autologous Bone Marrow Mononuclear Cells Transplantation Is Related to Stroke Outcome: Results from a Pooled Analysis of Two Clinical Trials.The possible roles of brain pericytes in brain ischemia and stroke.Intravascular stem cell transplantation for stroke.The potential role of perlecan domain V as novel therapy in vascular dementia.Understanding and preventing the development of post-stroke dementia.Lessons from a mouse model characterizing features of vascular cognitive impairment with white matter changesAutologous bone marrow mononuclear cell therapy for autism: an open label proof of concept study.Intraarterial transplantation of human umbilical cord blood mononuclear cells in hyperacute stroke improves vascular function.Lipo‑prostaglandin E1 modifies cognitive impairment in rats with vascular cognitive impairment by promoting angiogenesis via the VEGF/VEGFR pathway.The heart-brain connection: mechanistic insights and modelsIntra-arterial bone marrow mononuclear cell distribution in experimental global brain ischaemia.Intra-arterial bone marrow mononuclear cells (BM-MNCs) transplantation in acute ischemic stroke (IBIS trial): protocol of a phase II, randomized, dose-finding, controlled multicenter trial.Intra-arterial bone marrow mononuclear cell transplantation correlates with GM-CSF, PDGF-BB, and MMP-2 serum levels in stroke patients: results from a clinical trial.
P2860
Q26852526-C08B4E3F-6184-4F28-B1D4-13EB7D53428DQ27325132-D324F3DF-5CDE-46B0-AA11-AB5DFC090DC3Q28087451-38F7DB42-BACD-46DF-A2E2-5C3396E36E31Q28254272-7389FB4B-E2E7-4129-8B4A-A76FCB64627FQ28308195-1E66A7F1-97EB-4BC1-A143-CC0927746428Q30387946-2E0CCC58-5D8B-414F-A57E-02F1F35D0341Q30427103-E6BC0183-D50D-495E-B650-F6D5D836E9CAQ30574180-8037B0D8-6199-4BF0-94C0-0BA47D8E108FQ33936887-8F2BE638-32AE-4702-94C5-648C34EB6BC7Q34193407-D4379A7C-184E-431F-A61A-EEEDF164ABF0Q34360213-FB8B10A3-1B33-4C59-96F1-F359990A7666Q34392864-0ED6DE2E-8398-447A-B56D-873A9FBF1F1AQ36092131-2C77E52A-87AD-4837-BA96-F100A856B449Q36301669-F59688F4-3065-450D-9210-43E3204D4B87Q36615851-F6759511-FDF2-48EB-891C-40FBEB3999E1Q37150563-FDE26B10-F778-4ACA-8D46-BEF464E959B4Q37914769-29C98383-70EF-478A-855A-8A67B85BC296Q38170033-5B4B888A-98A5-471C-8BCC-DD75EE829C6FQ38223223-8A989AAD-2B84-418D-9088-ED2A7D5CFB8FQ38238144-01FD7D76-CEDF-4D01-83A2-474694939D22Q39114617-2AFDD284-F03F-4191-94F2-480F07167502Q39345467-A7957D47-F6AA-4B9B-BE2F-A72B937EEB65Q42314752-DB41109B-F15C-442E-9A20-DF00D98E3E54Q42546704-975BE0F0-10E4-432B-A8A2-09B2B1AD5CD3Q42770431-8FFC11CB-DED5-4A8E-BE3F-0257C7521603Q46121599-286F12E7-F5E9-49C2-8990-00D6819DD670Q48144302-58D4EC9F-FEDD-4C21-9FF7-D364EF44169EQ53082672-30F11AE5-9AAF-4E95-A37C-CD25768137B9
P2860
Early protective effect of bone marrow mononuclear cells against ischemic white matter damage through augmentation of cerebral blood flow.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Early protective effect of bon ...... tation of cerebral blood flow.
@ast
Early protective effect of bon ...... tation of cerebral blood flow.
@en
type
label
Early protective effect of bon ...... tation of cerebral blood flow.
@ast
Early protective effect of bon ...... tation of cerebral blood flow.
@en
prefLabel
Early protective effect of bon ...... tation of cerebral blood flow.
@ast
Early protective effect of bon ...... tation of cerebral blood flow.
@en
P2093
P1433
P1476
Early protective effect of bon ...... tation of cerebral blood flow.
@en
P2093
Hidefumi Ito
Hideyo Hirai
Masafumi Ihara
Masahiro Hiraoka
Ryosuke Takahashi
Shinae Kizaka-Kondoh
Takashi Ushiki
Youshi Fujita
P304
P356
10.1161/STROKEAHA.110.596379
P407
P577
2010-10-14T00:00:00Z